Skip to main content Skip to office menu Skip to footer
Minnesota Legislature
Office of the Revisor of Statutes

Office of the Revisor of Statutes

HF 4

Status in the House for the 91st Legislature (2019 - 2020)

Current bill text: As Introduced
Add HF 4 to MyBills
Version List
Companion: None
Senate Search
Revisor number: 19-1678
Long Description
Further Committee Actions
House Research Summary

Description

Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.

Authors

Actions

House

01/10/2019
Introduction and first reading, referred to Health and Human Services Policy
pg. 33 Intro
01/14/2019
Author added Mariani
pg. 50
02/07/2019
Committee report, to adopt as amended and re-refer to Commerce
pg. 218a